NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Sees Significant Growth in Short Interest

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the recipient of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 24,100 shares, a growth of 2,912.5% from the October 31st total of 800 shares. Based on an average daily volume of 8,500 shares, the short-interest ratio is currently 2.8 days.

NLS Pharmaceutics Price Performance

Shares of NASDAQ:NLSPW opened at $0.01 on Thursday. NLS Pharmaceutics has a 52-week low of $0.01 and a 52-week high of $0.17. The stock’s 50-day simple moving average is $0.01 and its two-hundred day simple moving average is $0.02.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).